Business Context and Reporting Period
This Form 6-K filing by Park Ha Biological Technology Co., Ltd. covers the month of March 2026, with a specific report date of March 16, 2026. The filing serves as a report of a material event regarding corporate governance rather than a financial performance update.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a corporate governance announcement and contains no financial data.
Material Changes
The primary material change disclosed is the resignation of Ms. Li Wang as a director of the Company, effective March 16, 2026. The Company explicitly states that this resignation was not the result of any disagreement with the Company's operations, policies, or procedures.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the director's resignation.
Investor Verification Checklist
- Verify the effective date of Ms. Li Wang's resignation (March 16, 2026).
- Confirm the stated reason for resignation (no disagreement with operations).
- Check for subsequent filings regarding the appointment of a replacement director.
- Note that no financial performance data is included in this specific filing.